Logo

Home

smallArrow

Stocks Screener

smallArrow

Panacea Biotec

Panacea Biotec Share Price

Panacea Biotec (INR)314.09-16.5   (-5%)

Exchange ScripsBSE531349NSEPANACEABIOISININE922B01023

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Panacea Biotec Performance

Market performance
Open price314.09
High314.09
Volumes28686
Prev Close314.09
Low314.09
Closing date2024-09-20
Historical performance
1 Year High367.27
3 Year High367.27
5 Year High449.00
1 Year Low112.35
3 Year Low107.00
5 Year Low85.95

Panacea Biotec Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
853
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-57.88
Dividend Yield
Dividend Yield
N/A

Panacea Biotec Investment Returns

1 Year
93.5%
3 Years
7.3%
5 Years
112.4%
10 Years
51.2%

Panacea Biotec Technicals

IndicatorsValueSignal
5-DMA335.14Bearish
10-DMA313Bullish
20-DMA274.93Bullish
50-DMA200.17Bullish
100-DMA167.54Bullish
200-DMA162.12Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors4550746236470854887247809
Government---------------

Panacea Biotec Financials

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021Mar-2020
Other Income517110100304
Operating Profit-463-22866558
Interest44180818531740
Depreciation391438456441
Profit Before Tax12814494-1442-1777
Consolidated Net Profit-33210783-1477-1943
Adjusted EPS-5176-24-32

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021Mar-2020
Share Capital61616161
Total Reserves83758705-23481607
Minority Interest-35-30-30-30
Total Non-Current Liabilities99285196007407
Total Liabilities12712173511177415585
Capital Work in Progress2804921295
Total Assets12712173511177415585

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021Mar-2020
Cash Flow from Operating Activities-4225-10841068-305
Cash Flow from Investing Activities430312826-477-348
Cash Flow from Financing Activitie-184-11758-471907
Net Cash Inflow / Outflow-105-17120255
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -57.88.
  • 3Y Stock Price CAGR of the stock is 2.5.
  • The stock has a beta of 1.2.
  • In the last financial year, the company had an EBITDA of ₹-463 Million.
  • The company generated revenue of ₹4599 Million in the previous financial year.

Panacea Biotec

314.09-16.5   (-5%)

Investment Amount: ₹ 15535
Current Value: ₹ 31409
Performence: 102.2%
P/L: ₹ 15874
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Syncom Formulations

▲ 39.5

22.71

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Jubilant Pharmova

▲ 34.5

1206.1

August 20 - September 20

Brooks Laboratories

▲ 33.6

147.47

August 20 - September 20

Nectar Lifesciences

▲ 29.9

42.25

August 20 - September 20

Biofil Chem & Pharma

▲ 29.7

83.6

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6